These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 25864137)
1. [The role of β-blockers in patients with metabolic syndrome and hypertension]. Dézsi CA Orv Hetil; 2015 Apr; 156(16):623-5. PubMed ID: 25864137 [TBL] [Abstract][Full Text] [Related]
2. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus. Fardoun RZ Pharmacotherapy; 2006 Oct; 26(10):1491-500. PubMed ID: 16999659 [TBL] [Abstract][Full Text] [Related]
3. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations? Hilgers KF; Mann JF Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734 [No Abstract] [Full Text] [Related]
4. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]
5. [Antihypertensive therapy with left cardiac insufficiency]. Schröder H Med Monatsschr Pharm; 2005 Dec; 28(12):443-4. PubMed ID: 16389872 [No Abstract] [Full Text] [Related]
6. The role of vasodilating beta-blockers in patients with hypertension and the cardiometabolic syndrome. Taylor AA; Bakris GL Am J Med; 2010 Jul; 123(7 Suppl 1):S21-6. PubMed ID: 20609696 [TBL] [Abstract][Full Text] [Related]
7. [Clinico-immunological disorders in patients with ischemic heart disease combined with metabolic syndrome and modulating effect of nebivolol for their correction]. Tepliakov AT; Bolotskaia LA; Vdovina TV; Stepacheva TA; Kuznetsova AV Ter Arkh; 2008; 80(12):44-52. PubMed ID: 19227907 [TBL] [Abstract][Full Text] [Related]
8. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome. Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337 [TBL] [Abstract][Full Text] [Related]
9. Hypertensive treatment in patients with metabolic syndrome. Siegel D; Swislocki AL Metab Syndr Relat Disord; 2010 Apr; 8(2):95-104. PubMed ID: 20156078 [TBL] [Abstract][Full Text] [Related]
10. The metabolic syndrome in hypertension: European society of hypertension position statement. Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G; J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611 [TBL] [Abstract][Full Text] [Related]
11. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases]. Baumgart P MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965 [No Abstract] [Full Text] [Related]
12. A second look at beta blockers and blood pressure. A beta blocker alone isn't usually the best choice for simple, uncomplicated high blood pressure. Harv Heart Lett; 2008 Jun; 18(10):4-5. PubMed ID: 18822509 [No Abstract] [Full Text] [Related]
13. Current role of beta-blockers in the treatment of hypertension. Aronow WS Expert Opin Pharmacother; 2010 Nov; 11(16):2599-607. PubMed ID: 20426702 [TBL] [Abstract][Full Text] [Related]
14. Treating hypertension in patients with ischaemic disease: the case for better beta-blocker usage. Cardiovasc J Afr; 2008; 19(2):113. PubMed ID: 18516359 [No Abstract] [Full Text] [Related]
15. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients. Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587 [TBL] [Abstract][Full Text] [Related]